| 000 | 01604 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514061654.0 | ||
| 264 | 0 | _c20030402 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0021-9738 | ||
| 024 | 7 |
_a10.1172/JCI16950 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKim, Yong-Mi | |
| 245 | 0 | 0 |
_aGraft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. _h[electronic resource] |
| 260 |
_bThe Journal of clinical investigation _cMar 2003 |
||
| 300 |
_a659-69 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFingolimod Hydrochloride |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xdrug therapy |
| 650 | 0 | 4 |
_aGraft vs Tumor Effect _xdrug effects |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 |
_aPropylene Glycols _xpharmacology |
| 650 | 0 | 4 |
_aSphingosine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 700 | 1 | _aSachs, Teviah | |
| 700 | 1 | _aAsavaroengchai, Wannee | |
| 700 | 1 | _aBronson, Roderick | |
| 700 | 1 | _aSykes, Megan | |
| 773 | 0 |
_tThe Journal of clinical investigation _gvol. 111 _gno. 5 _gp. 659-69 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI16950 _zAvailable from publisher's website |
| 999 |
_c12414178 _d12414178 |
||